Best Immunotherapy for lung cancer Doctors Worldwide — TOP 58

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Leading researcher in lung cancer immunotherapy – Dr. Raphael pioneers T-cell repertoire sequencing studies at Sourasky Medical Center.

• Principal investigator for multiple immunotherapy clinical trials in NSCLC
• Molecular Tumor Board moderator for Israeli Lung Cancer Society
• Specializes in genomic profiling and liquid biopsy techniques
• Honored as outstanding teacher at Tel-Aviv University
• Member of IASLC and ESMO oncology societies

Prof. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center with 41 years of experience in lung cancer immunotherapy research and treatment.

• Specializes in immunotherapy protocols for advanced lung cancer cases
• ESMO faculty member for sarcoma and thoracic oncology
• Former Chairman of Israel's Oncology and Radiotherapy Society
• Authored 50+ research papers on tumor immunology and targeted therapies

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Prof. Sezer Sağlam specializes in immunotherapy for lung cancer at Gayrettepe Florence Nightingale Hospital, one of Istanbul's leading oncology centers.

• Professor of Medical Oncology with extensive experience in gastrointestinal oncology
• Fellowship-trained at Istanbul University Medical Faculty
• Member of ESMO, ASCO, and European Neuroendocrine Tumour Society
• Works at American Cancer Center within Florence Nightingale Hospital

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Sinan Karaaslan specializes in immunotherapy for lung cancer at Anadolu Medical Center, with over a decade of focused oncology experience.

• Member of the Turkish Lung Cancer Society
• Trained in medical oncology at Istanbul University
• Works exclusively at a leading cancer center
• Specializes in breast, colorectal, and urogenital cancers

Specialist in oncology with training at Hacettepe University and MD Anderson Cancer Center.

• Completed fellowship at Hacettepe University Cancer Institute
• Experienced in treating lung cancer among other cancers
• Worked at prestigious institutions including MD Anderson Cancer Center
• Education includes specialization from Istanbul Sisli Etfal Training and Research Hospital

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 international publications and books to her name.

• Member of the European Society of Medical Oncology (ESMO)
• Professor at Halic University, Istanbul
• Trained in melanoma and kidney cancer immunotherapy at Mount Vernon Cancer Center
• Author of 'Handbook of Advanced Cancer Care Treatment'

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Dr. Vergés is a distinguished ophthalmologist with a PhD from Harvard and multiple national research awards, focusing on advanced eye care.

• Director of Ophthalmology at Dexeus University Hospital
• Specializes in cataract and neurophysiological vision mechanisms
• Recipient of the National Research Prize for tear secretion studies
• Member of the International Society of Refractive Surgery
• Published extensively in leading ophthalmology journals

Professor of Medical Oncology with over 29 years of experience of experience – Dr. Saglam specializes in lung cancer immunotherapy at Istanbul Florence Nightingale Hospital.

• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Former attending physician in Gastrointestinal Oncology

Chief Physician at a certified interdisciplinary cancer center – Phd Viola Fox specializes in immunotherapy and molecular diagnostics for lung cancer.

• 14 years of experience experience in hematology and oncology
• Specialized in immunotherapy, targeted therapy, and molecular diagnostics
• Active member of German and American cancer research societies
• Involved in molecular biology research for innovative treatments

Prof. Klepetko pioneered lung transplantation in Austria and leads Vienna's thoracic oncology program. His innovations have made Vienna a global hub for advanced lung surgery.

• Performed one of Austria's first lung transplants in 1989
• Head of Thoracic Surgery at Medical University of Vienna
• Specializes in minimally invasive thoracic surgery techniques
• Internationally recognized for lung transplantation advancements
• Trained generations of thoracic surgeons

Univ. Prof. Dr. Wolfgang Köstler specializes in targeted cancer therapies, with over two decades of experience in medical oncology.

• Expert in breast cancer and gynecologic malignancies
• Deputy Head of the Clinical Division of Oncology at Medical University of Vienna
• Focuses on biomarker development and resistance mechanisms
• Senior consultant at Wiener Privatklinik